MSD has confirmed a $3 billion takeover deal for ophthalmology biotech EyeBio and its drug candidate for diabetic macular oedema (DME) and neovascular age-related macular degeneration (AMD). The ...
MSD has acquired Yale University spinout Modifi Biosciences, claiming ownership of a potential new class of therapeutics for difficult-to-treat brain tumours, including glioblastomas. Under the terms ...
While there is little to know about macOS 16, it's likely that the system will see a signifcant design overhaul as Apple attempts to adopt a more cohesive design across all of its devices. Current ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results